Using the upstream regulator analysis routine of the IPA program, we were able to predict that Cisd2 expression at a level similar to that found in young WT mice affected a number of upstream regulators and that these regulators play important roles in attenuating liver steatosis. The gene discussed is CISD2; the disease is fatty liver disease.